AVE 16.7% 0.3¢ avecho biotechnology limited

'did not reach theraputic levels severe pain', page-7

  1. 5,796 Posts.
    lightbulb Created with Sketch. 736
    The bottom line is that the TPM patch is effective at delivering oxycodeine to a therapuetic level.
    Pain levels are subjective.
    A certain level of concentration has reached blood plasma levels.
    Somewhat greater levels need to be reached for theraputic levels for severe pain in a 7 day patch, but even oxycontin tablets may not reach that for very severe pain.

    I really don't think that this patch main directive is to treat severe pain with a patch, but more to treat CHRONIC PAIN with a patch.

    I will state that the majority of chronic pain is not bed riddling severe pain.
    Mutli-billion dollars are spent on daily chronic pain. OXYpatch may soon grab a fair chunk of that market.
  2. This thread is closed.

    You may not reply to this discussion at this time.

 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
-0.001(16.7%)
Mkt cap ! $7.923M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $3.226K 1.116M

Buyers (Bids)

No. Vol. Price($)
52 92468918 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 76402411 25
View Market Depth
Last trade - 12.50pm 06/09/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.